Todorović, S. (2023) “RISK OF COVID-19 INFECTION IN PATIENTS WITH MULTIPLE SCLEROSIS TREATED WITH OCRELIZUMAB – A SINGLE CENTER EXPERIENCE”, Acta medicae Medianae, 62(3). Available at: https://asistent.ceon.rs/index.php/amm/article/view/41552 (Accessed: 12 July 2026).